Life ScienceCompany
Sanofi - Surgestone Provames Tredemine and Speciafoldine Rights Ownership
Who owns Sanofi - Surgestone Provames Tredemine and Speciafoldine Rights?
Sanofi - Surgestone Provames Tredemine and Speciafoldine Rights is owned by Merus Labs International. It was acquired on March 7, 2016.
Sanofi - Surgestone Provames Tredemine and Speciafoldine Rights Business Overview
Where is Sanofi - Surgestone Provames Tredemine and Speciafoldine Rights headquartered?
Sanofi - Surgestone Provames Tredemine and Speciafoldine Rights is headquartered in France.
What sector is Sanofi - Surgestone Provames Tredemine and Speciafoldine Rights in?
Sanofi - Surgestone Provames Tredemine and Speciafoldine Rights is a life science company.
Life Science M&A Summary in 2016
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.
Join Mergr to view all 295 acquisitions of life science companies in 2016, including 33 acquisitions by private equity firms, and 262 by strategics.